These T cells express a resident memory T cell gene signature and high levels of exhaustion markers, and blockade of CD39/CD73 alone or combination with checkpoint blockade may be a promising therapeutic strategy to improve the anti-tumor potency of these CD103+ CD39+ T cells [158]. Here, NT5E is linked to neoplasm.